Condition
Group B Streptococcus Neonatal Sepsis
Total Trials
4
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown2
Active Not Recruiting1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT04549220Active Not Recruiting
Serosurveillance Study of Maternally Derived Anti-GBS Antibody
NCT04653948Unknown
Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital
NCT04732026Unknown
Serocorrelate of Protection Against GBS (PREPARE WP3)
NCT00331019WithdrawnPrimary
Rapid Detection of Group B Strep- 35-37 Week Study
Showing all 4 trials